530125 logo

Samrat Pharmachem Limited Stock Price

BSE:530125 Community·₹696.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

530125 Share Price Performance

₹0
-358.35 (-100.00%)
₹0
-358.35 (-100.00%)
Price ₹0

530125 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

3 Risks
0 Rewards

Samrat Pharmachem Limited Key Details

₹2.9b

Revenue

₹2.8b

Cost of Revenue

₹131.3m

Gross Profit

₹115.6m

Other Expenses

₹15.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 13, 2026
5.08
4.54%
0.54%
15.5%
View Full Analysis

About 530125

Founded
1992
Employees
28
CEO
Lalit Mehta
WebsiteView website
www.samratpharmachem.com

Samrat Pharmachem Limited engages in the manufacture and sale of pharmaceutical chemicals in India. It offers 3-5-di iodosalicylic acid, ammonium iodide, cadmium iodide, calcium iodate, clioquinol, copper iodide, ethyl iodide, ethylenediamine dihydroiodide, hydroiodic acid, iodine, iodine monochloride, iodoquinol, methyl iodide, n-iodo succinimide, periodic acid, potassium iodate and iodide, potassium metaper iodate, povidone iodine, sodium iodate and iodide, and sodium metaper iodate. The company serves the agrochemical, animal feed, chemical, cosmetics, food, pharmaceutical, printing, and textile industries. It also exports its products to the United States, Europe, Africa, Asia, the Middle East, and internationally. Samrat Pharmachem Limited was incorporated in 1992 and is based in Mumbai, India.

Recent 530125 News & Updates

Recent updates

No updates